North American
Medical Device Plastics Market to reach nearly 2.9 bn pounds by 2008
The use of
plastics in the healthcare field encompasses several distinct
markets-predominantly applications for medical devices and related
products, and packaging. Market research studies in the past have
often combined these two applications, which does not benefit
companies exclusively involved in either medical devices or medical
packaging. Healthcare players are vulnerable to a variety of
pressures, although the industry is in good shape, compared with
most others since the economic slowdown that started in the last
quarter of 2000. The healthcare industry has nowhere to go but up,
thanks to inexorable demographic trends, led by 75 million aging
baby boomers who will demand quality care.
According to a report
from Business Communications Company, Inc. ( http://www.bccresearch.com/
) RP-121U Plastics for Medical
Devices, the North American medical plastics market was estimated at
slightly over 2.2 billion pounds by the end of 2002. It is expected
to grow at an AAGR (average annual growth rate) of about 4.3%,
consuming almost 2.9 billion pounds by the year 2008. Disposable
medical devices comprise about 60% of the total volume for all
years.
Commodity
thermoplastics dominate the market with approximately 50% of total
volume for all years. In the aggregate, a slight shift from
commodity thermoplastics to engineering resins, styrenics,
thermosets and TPEs is forecast.
Major non-disposable
medical markets include testing/diagnostic equipment, surgical
instruments/related equipment, prostheses/ implants, and
dental/ophthalmic products. Disposable medical products include:
syringes, kits, lab ware, tubing, blood bags, fluid administration
systems, utensils, gloves, trays, catheters, thermometers, etc.
North American
Medical Plastics Market by Resin, through 2008
Particulars
|
2002
|
2003
|
2008
|
(Millions
Lbs.) AAGR % 2003-2008
|
Commodity
resins
|
1,192
|
1,250
|
1,529
|
4.1
|
Styrenics
|
364
|
382
|
472
|
4.3
|
Engineering
resins
|
236
|
244
|
308
|
4.8
|
Others*
|
436
|
459
|
579
|
4.8
|
Total
|
2,228
|
2,335
|
2,888
|
4.3
|
* Includes thermo
sets, TPEs and miscellaneous resins Source: BCC, Inc.
There are hundreds of
companies that convert resins derived from resin manufacturers into
medical devices. Some of these firms specialize in one or two
product areas; others supply a wide variety of products. The Food
& Drug Administration (FDA) exercises enormous control, since
"new" devices must have its approval before they can be
introduced into the marketplace.
Confronting the
industry are many conflicting and critical issues that will
significantly affect its growth and the demand for its plastic
products. Some of these issues are:
-
Shifts in medical
device sterilization technologies
-
Increases in
infectious diseases that result in increased usage of disposable
products
-
Changing FDA
regulations-mainly speeding up of new drug approvals
-
Moving of
healthcare payments from individual physicians and hospitals to
HMOs, nursing facilities and centralized purchasing
-
The trend toward
“defensive medicine,” primarily due to increased liability
law suits
-
An aging U.S.
population
-
New technologies,
the most recent of which include diagnostic imaging and laser
surgery, and polymers with improved biocompatibility properties
-
The continued
drive toward industry cost containment policies
-
Recent emphasis
on PVC alternatives.
**** |
|